Compare LFVN & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFVN | CGO |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 145.2M | 112.9M |
| IPO Year | N/A | N/A |
| Metric | LFVN | CGO |
|---|---|---|
| Price | $6.17 | $12.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 174.9K | 34.7K |
| Earning Date | 02-04-2026 | 01-01-0001 |
| Dividend Yield | 2.65% | ★ 9.25% |
| EPS Growth | ★ 143.91 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $228,877,000.00 | N/A |
| Revenue This Year | $1.54 | N/A |
| Revenue Next Year | $7.00 | N/A |
| P/E Ratio | $8.72 | ★ N/A |
| Revenue Growth | ★ 16.77 | N/A |
| 52 Week Low | $5.69 | $7.90 |
| 52 Week High | $27.38 | $10.93 |
| Indicator | LFVN | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 44.73 | 73.17 |
| Support Level | $5.80 | $11.38 |
| Resistance Level | $6.33 | $11.63 |
| Average True Range (ATR) | 0.34 | 0.12 |
| MACD | 0.07 | 0.07 |
| Stochastic Oscillator | 36.54 | 100.00 |
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.